Skip to content

Lily's Grace Temporal Interference

Using Temporal Interference to Non-Invasively Enhance Sleep Homeostasis in Patients With Epilepsy

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07520955
Acronym
SLEEP-TIES
Enrollment
24
Registered
2026-04-09
Start date
2026-09-01
Completion date
2028-09-01
Last updated
2026-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Keywords

seizures, non rapid eye movement sleep

Brief summary

This study is to evaluate the effectiveness of targeted Transcranial Electrical Stimulation with Temporal Interference (TES-TI) interventions to boost Non-Rapid Eye Movement (NREM) sleep, decrease seizures and promote emotional health in patients with epilepsy. Up to 24 participants (8 control participants for technical optimization prior to recruitment and 16 patients with epilepsy) will be enrolled and can expect to be on study for up to 24 months.

Detailed description

This is a Phase I randomized, single-blind, cross-over feasibility study comprised of 16 participants. Each participant will undergo structural and functional MRI then complete four nights of TES-TI stimulation and four nights of sham stimulation in counterbalanced order, separated by ≥1 day between visits. Conditions on each visit are randomized and counterbalanced. During each visit, participants will complete both the REST-Q and SSS questionnaires. Full HD-EEG will be applied as well as 4-16 stimulation electrodes. Participants will then undergo an emotion regulation task (face task) wherein they are presented with positive, negative, or neutral emotional stimuli. This is followed by a resting HD-EEG recording, then overnight stimulation. Either sham or non-sham (8 patients in each group) stimuli will be applied at times during the sleep period. Upon waking, the same questionnaires and emotion regulation tasks will be completed. Objectives: * Assess the efficacy of TES-TI to boost sleep NREM slow-wave activity and spindles in patients with epilepsy overnight * Assess the efficacy of TES-TI to improve sleep quality and mood (REST-Q) and sleepiness (sleepiness scale) after treatment (4 nights) vs. before * Assess the efficacy of TES-TI to improve emotion responses (face task) and vigilance (psychomotor vigilance task; PVT) after treatment (4 nights) vs. before * Assess the efficacy of TES-TI to improve restorative quality of sleep (REST-Q questionnaire) after treatment (4 nights) vs. before * Assess the efficacy of TES-TI to reduce seizure frequency (self-reported) after treatment (4 nights) vs. before

Interventions

DEVICETES-TI

Real stimulation will take place on visits 2 - 5 or visits 6 - 10.

OTHERSham Stimulation

Sham stimulation will take place on visits 2 - 5 or visits 6 - 10.

After baseline night visit 1 and before intervention visits 2 - 10. MRI is used to help determine electrode placement.

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER
Lily's Fund for Epilepsy Research
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* English-speaking (able to provide consent and complete questionnaires) * Citizen or holding permanent resident status * History of refractory epilepsy with intractable seizures and/or cognitive decline

Exclusion criteria

* Any current or past history of neurological disorders or acquired neurological disease other than epilepsy (e.g. stroke, traumatic brain injury), including intracranial lesions * Current history of poorly controlled headaches including intractable or poorly controlled migraines * Any systemic illness or unstable medical condition that may cause a medical emergency in case of a provoked seizure (cardiac malformation, cardiac dysrhythmia, asthma, etc.) * Possible pregnancy or plan to become pregnant in the next 6 months * Any metal in the head * Any metal in the body * Any medical devices or implants (i.e. cardiac pacemaker, medication infusion pump, cochlear implant, vagal nerve stimulator) unless otherwise approved by the responsible MD * Dental implants * Permanent retainers * Claustrophobia (a fear of small or closed places) * Back problems that would prevent lying flat for several hours * Regular night-shift work (second or third shift)

Design outcomes

Primary

MeasureTime frameDescription
NREM Sleep Slow-Wave Activity Measured by High-Density EEG (delta power)measured during 8 overnight visits, data collected up to 24 months on studyTo assess the effect of TES-TI on NREM sleep slow-wave activity during treatment (4 nights) vs. sham (4 nights), slow-wave activity will be measured by high-density EEG.
Number of Seizures per weekdata collected at 4 time points up to 24 months on study, 1 month and 3 month follow up after completion of 4 nights treatment and 1 month and 3 month follow up after completion 4 nights sham conditionTo assess the effect of TES-TI on incidence of seizures after treatment (4 nights) vs. sham (4 nights), participants will maintain a seizure diary. The self-reported number of seizures seizures per week for the first week and the first four-weeks post-intervention.
Psychomotor Vigilance Task (PVT)measured during 8 overnight visits, data collected up to 24 months on studyThe vigilance task will be used to assess the effect of TES-TI on performance after treatment (4 nights) vs. sham (4 nights). This is a computerized reaction time task where a participant is presented with a fixation point on a computer screen. At random, the fixation point will change appearance at which point the participant is to click a provided button as quickly as possible. The time it took to respond is recorded automatically by the computer program and will be reported as the result.
Restorative Sleep Questionnaire (REST-Q)measured during 8 overnight visits, data collected up to 24 months on studyThe REST-Q measure will be used to assess the effect of TES-TI on sleep quality and mood after treatment (4 nights) vs. sham (4 nights). It is a 9-item questionnaire assessing aspects of restorative sleep. Each item is scored on a 5-point Likert scale (1-light; 5-deep). Final scores are transformed to a scale of 0-100 here higher scores indicate more restorative sleep.
Stanford Sleepiness Scale (SSS)measured during 8 overnight visits, data collected up to 24 months on studyThe Stanford Sleepiness Scale will be used to assess sleepiness after treatment (4 nights) vs. sham (4 nights). SSS is a measure of subjective alertness on a 7-point scale (total range of scores from 1-7). A lower score on the scale indicates higher alertness.
Emotional Processing Task (Face Task): Percent Correctmeasured during 8 overnight visits, data collected up to 24 months on studyThe Face Task will be used to assess the effect of TES-TI on emotion response after treatment (4 nights) vs. sham (4 nights). This task involves viewing a series of emotionally charged images (60 positive, 60 negative, 60 neutral).
Emotional Processing Task (Face Task): Percent Change in Reaction Timemeasured during 8 overnight visits, data collected up to 24 months on studyThe Face Task will be used to assess the effect of TES-TI on emotion response after treatment (4 nights) vs. sham (4 nights). This task involves viewing a series of emotionally charged images (60 positive, 60 negative, 60 neutral).

Countries

United States

Contacts

CONTACTMelanie Boly, MD, PhD
boly@neurology.wisc.edu608-263-4338
CONTACTBeril Mat, MD
mat@wisc.edu
PRINCIPAL_INVESTIGATORMelanie Boly, MD, PhD

UW School of Medicine and Public Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 29, 2026